Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel E Furst

Showing results (381-390 of 477) with videos related to

Pageof 48
Sort By:
The Journal of Rheumatology|May 3, 2019
Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology TrialsLouise Klokker, Dorthe B Berthelsen, Thasia Woodworth, et al.
Seminars in Arthritis and Rheumatism|October 1, 2023
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature reviewCorrado Campochiaro, Yossra A Suliman, Michael Hughes, et al.
Rheumatology (Oxford, England)|June 19, 2023
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature reviewLaura Ross, Nancy Maltez, Michael Hughes, et al.
Annals of the Rheumatic Diseases|May 1, 2020
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient managementMarco Matucci-Cerinic, Cosimo Bruni, Yannick Allanore, et al.
The Journal of Rheumatology|February 17, 2015
Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group PlenarySusan J Bartlett, Vivian P Bykerk, Roxanne Cooksey, et al.
RMD Open|June 3, 2016
Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain SetVivian P Bykerk, Clifton O Bingham, Ernest H Choy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2003
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseasesRichard A Nash, Roger Dansey, Jan Storek, et al.
The Journal of Rheumatology|March 4, 2014
Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare WorkshopVivian P Bykerk, Elisabeth Lie, Susan J Bartlett, et al.
Rheumatology (Oxford, England)|June 18, 2021
Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritisDaniel E Furst, Janusz Jaworski, Rafal Wojciechowski, et al.
Annals of the Rheumatic Diseases|March 24, 2012
IRF5 polymorphism predicts prognosis in patients with systemic sclerosisRoozbeh Sharif, Maureen D Mayes, Filemon K Tan, et al.
Pageof 48

Showing results (381-390 of 477) with videos related to

Sort By:
Pageof 48
The Journal of Rheumatology|May 3, 2019
Identifying Possible Outcome Domains from Existing Outcome Measures to Inform an OMERACT Core Domain Set for Safety in Rheumatology TrialsLouise Klokker, Dorthe B Berthelsen, Thasia Woodworth, et al.
Seminars in Arthritis and Rheumatism|October 1, 2023
Non-surgical local treatments of digital ulcers in systemic sclerosis: a systematic literature reviewCorrado Campochiaro, Yossra A Suliman, Michael Hughes, et al.
Rheumatology (Oxford, England)|June 19, 2023
Systemic pharmacological treatment of digital ulcers in systemic sclerosis: a systematic literature reviewLaura Ross, Nancy Maltez, Michael Hughes, et al.
Annals of the Rheumatic Diseases|May 1, 2020
Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient managementMarco Matucci-Cerinic, Cosimo Bruni, Yannick Allanore, et al.
The Journal of Rheumatology|February 17, 2015
Feasibility and Domain Validation of Rheumatoid Arthritis (RA) Flare Core Domain Set: Report of the OMERACT 2014 RA Flare Group PlenarySusan J Bartlett, Vivian P Bykerk, Roxanne Cooksey, et al.
RMD Open|June 3, 2016
Identifying flares in rheumatoid arthritis: reliability and construct validation of the OMERACT RA Flare Core Domain SetVivian P Bykerk, Clifton O Bingham, Ernest H Choy, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2003
Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after high-dose immunosuppressive therapy and autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseasesRichard A Nash, Roger Dansey, Jan Storek, et al.
The Journal of Rheumatology|March 4, 2014
Establishing a core domain set to measure rheumatoid arthritis flares: report of the OMERACT 11 RA flare WorkshopVivian P Bykerk, Elisabeth Lie, Susan J Bartlett, et al.
Rheumatology (Oxford, England)|June 18, 2021
Efficacy and safety of switching from reference adalimumab to CT-P17 (100 mg/ml): 52-week randomized, double-blind study in rheumatoid arthritisDaniel E Furst, Janusz Jaworski, Rafal Wojciechowski, et al.
Annals of the Rheumatic Diseases|March 24, 2012
IRF5 polymorphism predicts prognosis in patients with systemic sclerosisRoozbeh Sharif, Maureen D Mayes, Filemon K Tan, et al.
Pageof 48